Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion type Assertion NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_head.
- NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_provenance.
- NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion evidence source_evidence_literature NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_provenance.
- NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion SIO_000772 11919393 NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_provenance.
- NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion wasDerivedFrom befree-2016 NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_provenance.
- NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_assertion wasGeneratedBy ECO_0000203 NP349702.RAnOLnay_Dscv18xSOW3mb-tjfFL9mCTXde0Cb-Z1v774130_provenance.